Unspecified type of carcinoma in situ of right breast
ICD-10 D05.91 is a billable code used to indicate a diagnosis of unspecified type of carcinoma in situ of right breast.
Carcinoma in situ (CIS) of the breast is a non-invasive form of breast cancer where abnormal cells are found in the lining of the breast ducts or lobules but have not spread to surrounding tissues. The unspecified type indicates that the specific histological subtype of carcinoma in situ has not been determined. This condition is often detected through mammography or breast biopsy and is characterized by the presence of atypical cells that have the potential to develop into invasive cancer if left untreated. Surveillance protocols typically involve regular imaging studies and clinical examinations to monitor for any changes in the breast tissue. The risk of progression to invasive carcinoma varies based on factors such as the patient's age, family history, and the presence of other risk factors. Early detection and treatment are crucial in managing this condition, as timely intervention can significantly reduce the risk of progression to invasive breast cancer.
Detailed pathology reports, imaging studies, and treatment plans.
Initial diagnosis of carcinoma in situ, treatment planning, and follow-up care.
Ensure accurate staging and histological classification to guide treatment.
Clear imaging reports indicating findings related to carcinoma in situ.
Mammography findings leading to biopsy recommendations.
Documentation must correlate with clinical findings and treatment decisions.
Used when excising a carcinoma in situ lesion.
Pathology report confirming carcinoma in situ.
Oncology specialists must ensure accurate coding based on surgical findings.
Carcinoma in situ refers to a group of abnormal cells that are confined to the site of origin and have not invaded surrounding tissues. It is considered a non-invasive form of cancer.
